Dna repair drugs

Global DNA Repair Drugs Market Size by Drug Type (Niraparib, Olaparib), by Application (Ovarian Cancer, Peritoneal Cancer), by Distribution Channel, by Mechanism of Action, & Region - Key Manufacturers, Analysis, Growth Trends, and Forecast till 2026

Category: Medical Devices     ID: IRP1843     Date: Oct, 2020
The global DNA repair drugs market was estimated to be valued at USD XX million in 2015 and is projected to reach USD XX million/billion by 2026, at a CAGR of XX% during 2019 to 2026. Scope of global DNA repair drugs market includes by drug type (Niraparib, Olaparib, Rucaparib), by application (Ovarian Cancer, Peritoneal Cancer, Breast Cancer, Gastric Cancer, Fallopian Tube Cancer), by distribution channel (Hospital Pharmacy, Online Pharmacy), by mechanism of action (Base Excision Repair, Homologous Recombination, Mismatch Repair, Others), and by region (North America- U.S., Canada; Europe- U.K., France, Germany; Asia-Pacific- China, Japan, India; Latin America- Brazil, Mexico; Middle East & Africa- South Africa, Saudi Arabia).
DNA or Deoxyribonucleic acid is a molecule composed of two polynucleotide chains that coil around each other to form a double helix carrying genetic instructions for development, functioning, growth, and reproduction of all known organisms and many viruses. Moreover, defects, or damage in DNA structure leads to genetic disorders, and to treat these genetic disorders DNA repairing drugs are used. DNA repair drugs are widely used to treat various type of cancer, such as ovarian cancer, peritoneal cancer, breast cancer, gastric cancer, and fallopian tube cancer which make DNA repair drugs more significant product across the globe.
One of the major applications of DNA repair drugs is in the healthcare industry, which is a key factor stimulating the DNA repair Drugs market growth over the forecast period. It is widely used for the treatment of damaged DNA, and different type of cancer such as ovarian, breast, gastric, and fallopian tube cancer. Moreover, the healthcare industry is growing at an unprecedented rate across the globe, this growth is attributable to the rising investment in the industry. The rapid increase in the number of people suffering from cancer is the major factors in driving the market growth across the globe. Moreover, the rapid increase in the adoption of these drugs among the people suffering from breast cancer is the key factor increasing the demand of DNA repair drugs in the market in the coming years. The top players of market, along with the government have been taking initiatives in order to create awareness for cancer treatment with the help of these drug is the key factor driving the market growth over the forecast period.
However, the high cost and delays in regulatory approvals of DNA repair drugs is expected to restrain the product demand over the coming years. With the help of advanced technology, the top players of market are taking initiatives for the development of novel drugs with higher efficiency in the treatment of various cancer, that will be the key factor in increasing the product demand in the coming years. The North America, Europe, and Asia Pacific region is witness to have a significant market growth rate, owing to increase in the number of patients suffering from cancer, and due to the rapid rise in healthcare expenditure.
The global DNA repair drugs market is primarily segmented by drug type, application, distribution channel, mechanism of action, and region.

In terms of drug type, the market is split into:
* Niraparib
* Olaparib
* Rucaparib

In terms of application, the market is divided into:
* Ovarian Cancer
* Peritoneal Cancer
* Breast Cancer
* Gastric Cancer
* Fallopian Tube Cancer

On the distribution channel front, the market is segmented into:
* Hospital Pharmacy
* Online Pharmacy



In terms of mechanism of action, the market is divided into:
* Base Excision Repair
* Homologous Recombination
* Mismatch Repair
* Others
The market is classified across regions and countries as follows:
* North America- U.S., Canada
* Europe- Russia, U.K., France, Germany, Italy
* Asia-Pacific- China, Japan, India, Australia
* Latin America- Brazil, Mexico
* Middle East & Africa- South Africa, Egypt, Saudi Arabia

Key Market Players:
The key players profiled in the market include:
* Johnson & Johnson Services, Inc.
* Karyopharm Therapeutics Company
* Pfizer, Inc.
* Artios Pharma
* AstraZeneca PLC
* Clovis Oncology
* Ono Pharmaceutical Co., LTD
* Repare Therapeutics Inc
* Karyopharm Therapeutics
* Genentech
* 4SC AG
* GlaxoSmithKline

These enterprises have been focusing on development strategies, such as expansions, new product launches, agreements & partnerships, and acquisitions to expand their business across the globe.
Key Benefits of the Report:
* Global, regional, country, drug type, distribution channel, mechanism of action, and application market size and their forecast from 2015-2026
* Identification and detailed analysis and insights on key market dynamics, such as drivers, opportunities, restraints, and challenges influencing the growth of the market
* Detailed analysis and insights on industry outlook with market specific PESTLE analysis, Porter’s Five Forces analysis, and Value Chain analysis, to achieve a better understanding of the market and prepare expansion strategies
* Identification and comprehensive analysis of key market players and their market share, detailed financial positions, key products, core competencies, and unique selling points
* Identification and analysis of Key players’ competitive developments and strategic initiatives, such as mergers, joint ventures, sales contracts, and new product introduction in the market
* Expert interviews and their insights on current and future outlook, market shift, and factors impacting vendors’ short term and long term strategies
* Detailed insights on emerging regions, drug type, distribution channel, mechanism of action, and application with qualitative and quantitative information and facts
* Identification of the key patents filed in the field of DNA repair drugs
* Owing to the volatility seen in the market due to the Global COVID-19 pandemic, businesses around the globe wish to know the impact on their market and how this changes the projections for 2020 and the forthcoming years. Orian Research is in talks with seasoned market analysts and key note speakers to understand the impact of COVID 19 on markets and factors that will bring in stability in the foreseeable future

Target Audience:
* DNA Repair Drugs manufacturer & Drug type Providers
* Traders, Importers, and Exporters
* Raw Material Suppliers and Distributors
* Research and Consulting Firms
* Government and Research Organizations
* Associations and Industry Bodies

Research Methodology:
The market is derived through extensive use of secondary, primary, in-house research followed by expert validation and third party perspective, such as, analyst reports of investment banks. The secondary research is the primary base of our study wherein we conducted extensive data mining, referring to verified data sources, such as, white papers, government and regulatory published articles, technical journals, trade magazines, and paid data sources.
For forecasting, regional demand & supply factors, recent investments, market dynamics including technical growth scenario, consumer behavior, and end use trends and dynamics, and production capacity were taken into consideration. Different weightages have been assigned to these parameters and quantified their market impacts using the weighted average analysis to derive the market growth rate.

The market estimates and forecasts have been verified through exhaustive primary research with the Key Industry Participants (KIPs), which typically include:
* Manufacturers
* Suppliers
* Distributors
* Raw Material Providers
* Government Body & Associations
* Research Institutes

Project Analysis

The project analyst providers critical data support to technical Research and analysis functions may include sed budget tracking financial sed forecasting projects evaluation monitoring, maintanence compliance regulations and performing establisheed fact that a readers. Project it is a long establisheed that a will be ut distracted by that readable content.
  • Improve sales and operations and production planning
  • Determine the right inventory level
  • Optimize the supply chain for perfect order planning
  • Designed we immediately begin to think positively